Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schänzer W[au]:

Creatine and creatine forms intended for sports nutrition. Andres S et al. Mol Nutr Food Res. (2017)

Detection of SARMs in doping control analysis. Thevis M et al. Mol Cell Endocrinol. (2018)

Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M et al. Drug Test Anal. (2017)

Search results

Items: 1 to 50 of 330

1.

SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins.

Reichel C, Gmeiner G, Reihlen P, Thevis M, Schänzer W.

Methods Mol Biol. 2019;1855:131-149. doi: 10.1007/978-1-4939-8793-1_14.

PMID:
30426415
2.

Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls.

Piper T, Dib J, Putz M, Fusshöller G, Pop V, Lagojda A, Kuehne D, Geyer H, Schänzer W, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1646-1656. doi: 10.1002/dta.2527. Epub 2018 Nov 18.

PMID:
30379415
3.

Androgen- and estrogen-receptor mediated activities of 4-hydroxytestosterone, 4-hydroxyandrostenedione and their human metabolites in yeast based assays.

Keiler AM, Zierau O, Wolf S, Diel P, Schänzer W, Vollmer G, Machalz D, Wolber G, Parr MK.

Toxicol Lett. 2018 Aug;292:39-45. doi: 10.1016/j.toxlet.2018.04.026. Epub 2018 Apr 24.

PMID:
29702199
4.

Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS.

Walpurgis K, Thomas A, Dellanna F, Schänzer W, Thevis M.

Proteomics Clin Appl. 2018 May;12(3):e1700120. doi: 10.1002/prca.201700120. Epub 2018 Jan 19.

PMID:
29226558
5.

Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports.

Thomas A, Knoop A, Schänzer W, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1799-1803. doi: 10.1002/dta.2306. Epub 2017 Nov 13.

PMID:
28941172
6.

Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection.

Piper T, Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Schänzer W, Thevis M.

Forensic Sci Int. 2017 Oct;279:157-164. doi: 10.1016/j.forsciint.2017.08.023. Epub 2017 Aug 26.

PMID:
28869822
7.

Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry.

Piper T, Putz M, Schänzer W, Pop V, McLeod MD, Uduwela DR, Stevenson BJ, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1695-1703. doi: 10.1002/dta.2291. Epub 2017 Oct 27.

PMID:
28836353
8.

Nutrition Status of Young Elite Female German Football Players.

Braun H, von Andrian-Werburg J, Schänzer W, Thevis M.

Pediatr Exerc Sci. 2018 Feb 1;30(1):157-167. doi: 10.1123/pes.2017-0072. Epub 2017 Oct 20.

PMID:
28787242
9.

Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications.

Thomas A, Schänzer W, Thevis M.

Expert Rev Proteomics. 2017 Sep;14(9):799-807. doi: 10.1080/14789450.2017.1362338. Epub 2017 Aug 4. Review.

PMID:
28758805
10.

Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS.

Thomas A, Walpurgis K, Delahaut P, Fichant E, Schänzer W, Thevis M.

Growth Horm IGF Res. 2017 Aug;35:33-39. doi: 10.1016/j.ghir.2017.06.002. Epub 2017 Jun 27.

PMID:
28668757
11.

Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.

Thevis M, Krug O, Geyer H, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Aug 15;31(15):1290-1296. doi: 10.1002/rcm.7903.

12.

Do we excrete what we eat? Analysis of stable nitrogen isotope ratios of human urinary urea.

Hülsemann F, Koehler K, Flenker U, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Jul 30;31(14):1221-1227. doi: 10.1002/rcm.7891.

PMID:
28466567
13.

Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes.

Thevis M, Piper T, Dib J, Lagojda A, Kühne D, Packschies L, Geyer H, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Jul 30;31(14):1175-1183. doi: 10.1002/rcm.7886.

PMID:
28440570
14.

lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.

Eichner D, Van Wagoner RM, Brenner M, Chou J, Leigh S, Wright LR, Flippin LA, Martinelli M, Krug O, Schänzer W, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1768-1778. doi: 10.1002/dta.2202. Epub 2017 May 31.

PMID:
28378453
15.

Prediction of human dietary δ15N intake from standardised food records: validity and precision of single meal and 24-h diet data.

Hülsemann F, Koehler K, Wittsiepe J, Wilhelm M, Hilbig A, Kersting M, Braun H, Flenker U, Schänzer W.

Isotopes Environ Health Stud. 2017 Aug;53(4):356-367. doi: 10.1080/10256016.2017.1302447. Epub 2017 Mar 15.

PMID:
28292192
16.

The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers.

Görgens C, Guddat S, Bosse C, Geyer H, Pop V, Schänzer W, Thevis M.

J Pharm Biomed Anal. 2017 May 10;138:175-179. doi: 10.1016/j.jpba.2017.02.011. Epub 2017 Feb 6.

PMID:
28213178
17.

Detection of SARMs in doping control analysis.

Thevis M, Schänzer W.

Mol Cell Endocrinol. 2018 Mar 15;464:34-45. doi: 10.1016/j.mce.2017.01.040. Epub 2017 Jan 27. Review.

PMID:
28137616
18.

Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.

Buntenkötter K, Osmers M, Schenk I, Schänzer W, Machnik M, Düe M, Kietzmann M.

BMC Vet Res. 2017 Jan 19;13(1):28. doi: 10.1186/s12917-017-0955-1.

19.

Creatine and creatine forms intended for sports nutrition.

Andres S, Ziegenhagen R, Trefflich I, Pevny S, Schultrich K, Braun H, Schänzer W, Hirsch-Ernst KI, Schäfer B, Lampen A.

Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600772. Epub 2017 Mar 30. Review.

PMID:
28019093
20.

Annual banned-substance review: analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H, Schänzer W.

Drug Test Anal. 2017 Jan;9(1):6-29. doi: 10.1002/dta.2139. Review.

PMID:
27885819
21.

Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.

Görgens C, Guddat S, Thomas A, Wachsmuth P, Orlovius AK, Sigmund G, Thevis M, Schänzer W.

J Pharm Biomed Anal. 2016 Nov 30;131:482-496. doi: 10.1016/j.jpba.2016.09.015. Epub 2016 Sep 15.

PMID:
27693991
22.

Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations.

Machnik M, Kaiser S, Koppe S, Kietzmann M, Schenk I, Düe M, Thevis M, Schänzer W, Toutain PL.

Drug Test Anal. 2017 Sep;9(9):1372-1384. doi: 10.1002/dta.2097. Epub 2016 Nov 4.

PMID:
27662634
23.

Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.

Piper T, Schänzer W, Thevis M.

Drug Test Anal. 2016 Nov;8(11-12):1163-1173. doi: 10.1002/dta.2095. Epub 2016 Oct 13.

PMID:
27649524
24.

Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS.

Walpurgis K, Thomas A, Vogel M, Reichel C, Geyer H, Schänzer W, Thevis M.

Drug Test Anal. 2016 Nov;8(11-12):1152-1161. doi: 10.1002/dta.2093. Epub 2016 Oct 13. Erratum in: Drug Test Anal. 2016 Nov;8(11-12):1162.

PMID:
27649383
25.

Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.

Helmlin HJ, Mürner A, Steiner S, Kamber M, Weber C, Geyer H, Guddat S, Schänzer W, Thevis M.

Forensic Sci Int. 2016 Oct;267:166-172. doi: 10.1016/j.forsciint.2016.08.029. Epub 2016 Aug 28.

PMID:
27611956
26.

Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry.

Vogel M, Dib J, Tretzel L, Piper T, Thomas A, Schänzer W, Thevis M.

Anal Bioanal Chem. 2016 Sep;408(23):6431-42. doi: 10.1007/s00216-016-9761-z. Epub 2016 Jul 20.

PMID:
27438721
27.

Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes.

Lagojda A, Kuehne D, Krug O, Thomas A, Wigger T, Karst U, Schänzer W, Thevis M.

Eur J Mass Spectrom (Chichester). 2016;22(2):49-59. doi: 10.1255/ejms.1415.

PMID:
27419898
28.

Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.

Dib J, Mongongu C, Buisson C, Molina A, Schänzer W, Thuss U, Thevis M.

Drug Test Anal. 2017 Jan;9(1):61-67. doi: 10.1002/dta.2011. Epub 2016 Jun 27.

PMID:
27346747
29.

Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes.

Tretzel L, Görgens C, Geyer H, Thomas A, Dib J, Guddat S, Pop V, Schänzer W, Thevis M.

Int J Sports Med. 2016 Jun;37(6):500-2. doi: 10.1055/s-0036-1582317. Epub 2016 May 4. No abstract available.

30.

Sports drug testing using complementary matrices: Advantages and limitations.

Thevis M, Geyer H, Tretzel L, Schänzer W.

J Pharm Biomed Anal. 2016 Oct 25;130:220-230. doi: 10.1016/j.jpba.2016.03.055. Epub 2016 Mar 28. Review.

PMID:
27040951
31.

Identification and characterization of in vitro and in vivo generated metabolites of the adiponectin receptor agonists AdipoRon and 112254.

Dib J, Thomas A, Delahaut P, Fichant E, Schänzer W, Thevis M.

J Pharm Biomed Anal. 2016 Jun 5;125:68-76. doi: 10.1016/j.jpba.2016.03.027. Epub 2016 Mar 14.

PMID:
27003122
32.

Mitragynine (Kratom) - monitoring in sports drug testing.

Guddat S, Görgens C, Steinhart V, Schänzer W, Thevis M.

Drug Test Anal. 2016 Nov;8(11-12):1114-1118. doi: 10.1002/dta.1970. Epub 2016 Mar 22.

PMID:
27001139
33.

Nickel in equine sports drug testing - pilot study results on urinary nickel concentrations.

Thevis M, Machnik M, Schenk I, Krug O, Piper T, Schänzer W, Düe M, Bondesson U, Hedeland M.

Rapid Commun Mass Spectrom. 2016 Apr 15;30(7):982-4. doi: 10.1002/rcm.7528.

PMID:
26969941
34.

Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing.

Tretzel L, Thomas A, Piper T, Hedeland M, Geyer H, Schänzer W, Thevis M.

J Pharm Biomed Anal. 2016 May 10;123:132-40. doi: 10.1016/j.jpba.2016.02.009. Epub 2016 Feb 10.

PMID:
26896632
35.

Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.

Knoop A, Thomas A, Fichant E, Delahaut P, Schänzer W, Thevis M.

Anal Bioanal Chem. 2016 May;408(12):3145-53. doi: 10.1007/s00216-016-9377-3. Epub 2016 Feb 15.

36.

Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.

Thevis M, Schänzer W.

Rapid Commun Mass Spectrom. 2016 Mar 15;30(5):635-51. doi: 10.1002/rcm.7470.

PMID:
26842585
37.

Annual banned-substance review: analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Walpurgis K, Geyer H, Schänzer W.

Drug Test Anal. 2016 Jan;8(1):7-29. doi: 10.1002/dta.1928. Epub 2016 Jan 15. Review.

PMID:
26767774
38.

Solutions Advertised as Erythropoiesis-stimulating Products were Found to Contain Undeclared Cobalt and Nickel Species.

Thevis M, Krug O, Piper T, Geyer H, Schänzer W.

Int J Sports Med. 2016 Jan;37(1):82-4. doi: 10.1055/s-0035-1569350. Epub 2016 Jan 7. No abstract available.

PMID:
26742015
39.

Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry.

Piper T, Schänzer W, Thevis M.

J Steroid Biochem Mol Biol. 2016 Sep;162:80-91. doi: 10.1016/j.jsbmb.2015.12.013. Epub 2015 Dec 14. Review.

PMID:
26699683
40.

Optimizing SAR-PAGE.

Reihlen P, Blobel M, Kempkes R, Reichel C, Völker Schänzer E, Majer B, Schänzer W.

Drug Test Anal. 2015 Nov-Dec;7(11-12):1014-6. doi: 10.1002/dta.1915. Epub 2015 Nov 26. No abstract available.

PMID:
26607413
41.

Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

Thomas A, Görgens C, Guddat S, Thieme D, Dellanna F, Schänzer W, Thevis M.

J Sep Sci. 2016 Jan;39(2):333-41. doi: 10.1002/jssc.201501060. Epub 2015 Dec 15.

PMID:
26578461
42.

Metabolism of human insulin after subcutaneous administration: A possible means to uncover insulin misuse.

Thomas A, Brinkkötter P, Schänzer W, Thevis M.

Anal Chim Acta. 2015 Oct 15;897:53-61. doi: 10.1016/j.aca.2015.09.036. Epub 2015 Oct 9.

PMID:
26515005
43.

Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.

Thevis M, Dib J, Thomas A, Höppner S, Lagojda A, Kuehne D, Sander M, Opfermann G, Schänzer W.

Drug Test Anal. 2015 Nov-Dec;7(11-12):1050-6. doi: 10.1002/dta.1907. Epub 2015 Oct 30.

PMID:
26514814
44.

Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.

Sigmund G, Dib J, Tretzel L, Piper T, Bosse C, Schänzer W, Thevis M.

Drug Test Anal. 2015 Nov-Dec;7(11-12):1057-62. doi: 10.1002/dta.1909. Epub 2015 Oct 20.

PMID:
26481102
45.

Global spatial distributions of nitrogen and carbon stable isotope ratios of modern human hair.

Hülsemann F, Lehn C, Schneider S, Jackson G, Hill S, Rossmann A, Scheid N, Dunn PJ, Flenker U, Schänzer W.

Rapid Commun Mass Spectrom. 2015 Nov 30;29(22):2111-21. doi: 10.1002/rcm.7370.

PMID:
26467223
46.

Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.

Thomas A, Walpurgis K, Tretzel L, Brinkkötter P, Fichant E, Delahaut P, Schänzer W, Thevis M.

Drug Test Anal. 2015 Nov-Dec;7(11-12):990-8. doi: 10.1002/dta.1868. Epub 2015 Sep 18.

PMID:
26382721
47.

Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.

Thevis M, Milosovich S, Licea-Perez H, Knecht D, Cavalier T, Schänzer W.

Drug Test Anal. 2016 Aug;8(8):858-63. doi: 10.1002/dta.1870. Epub 2015 Sep 11.

PMID:
26361079
48.

Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.

Thevis M, Geyer H, Thomas A, Tretzel L, Bailloux I, Buisson C, Lasne F, Schaefer MS, Kienbaum P, Mueller-Stoever I, Schänzer W.

J Pharm Biomed Anal. 2015 Nov 10;115:208-13. doi: 10.1016/j.jpba.2015.07.017. Epub 2015 Jul 22.

PMID:
26226108
49.

Myostatin inhibitors in sports drug testing: Detection of myostatin-neutralizing antibodies in plasma/serum by affinity purification and Western blotting.

Walpurgis K, Thomas A, Schänzer W, Thevis M.

Proteomics Clin Appl. 2016 Feb;10(2):195-205. doi: 10.1002/prca.201500043. Epub 2015 Oct 23.

PMID:
26223570
50.

Human sports drug testing by mass spectrometry.

Schänzer W, Thevis M.

Mass Spectrom Rev. 2017 Jan;36(1):16-46. doi: 10.1002/mas.21479. Epub 2015 Jul 24. Review.

PMID:
26213263

Supplemental Content

Loading ...
Support Center